γS-crystallin inhibitors represent a unique class of chemical compounds that interact with γS-crystallin, a protein found predominantly in the vertebrate lens. γS-crystallin is part of the larger crystallin family of proteins, which are crucial for maintaining the transparency and refractive properties of the lens. Structurally, γS-crystallin is characterized by its compact, globular nature, with two distinct domains that contribute to its stability. These domains form a Greek-key motif, a common fold in crystallin proteins that is essential for maintaining their solubility and resistance to aggregation under physiological conditions. Inhibitors of γS-crystallin are typically designed to modulate the structural conformation of this protein, preventing misfolding or aggregation, which can alter the physical properties of crystallins. Such inhibitors can be highly selective, targeting specific binding pockets or surface regions of the protein that are critical for its proper folding and function.
From a chemical perspective, γS-crystallin inhibitors often contain molecular scaffolds that enable them to interact with the hydrophobic or hydrophilic regions of the γS-crystallin structure. These inhibitors may act by binding to destabilized forms of the protein, thereby preventing the self-association that leads to protein aggregation. Many γS-crystallin inhibitors are derived from small organic molecules, peptides, or synthetic mimetics that are engineered to specifically interfere with the key molecular interactions that regulate γS-crystallin stability. By modulating these interactions, these inhibitors serve as tools for studying the biophysical properties of crystallins in detail, providing insights into how their conformation and behavior under stress conditions affect the overall protein network within the lens. Additionally, the chemistry behind these inhibitors often involves precise optimization of binding affinity and specificity, allowing researchers to probe the folding pathways and dynamics of γS-crystallin at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may cause hyperacetylation of histones, potentially leading to the downregulation of gene transcription, including the gene for γS-crystallin. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could decrease methylation levels of the γS-crystallin gene promoter, leading to reduced transcription of the gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A could bind to GC-rich sequences in the DNA, possibly leading to decreased transcriptional activity of the γS-crystallin gene. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D may intercalate into DNA, leading to the inhibition of RNA polymerase movement and reduced mRNA synthesis for γS-crystallin. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide might block the translocation step in protein synthesis, causing a reduction in γS-crystallin protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin could inhibit the mTOR pathway, leading to decreased protein synthesis rates and potentially lower levels of γS-crystallin. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $53.00 | 10 | |
Chloramphenicol might inhibit peptidyl transferase activity of the mitochondrial ribosome, potentially decreasing the synthesis of mitochondrial proteins, which may indirectly decrease γS-crystallin expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin may cause the premature release of nascent polypeptide chains, possibly leading to a general decrease in protein levels, including γS-crystallin. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin could downregulate the expression of certain genes by inhibiting kinases and transcription factors that control gene expression, potentially reducing γS-crystallin levels. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin may inhibit transcription factors such as NF-κB, which could lead to decreased expression of target genes, potentially including γS-crystallin. | ||||||